
















































Management of tooth extraction in a patient with
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Abstract
Introduction: Cyclic neutropenia (CyN) is a rare hematological disease, and patients with CyN often experience an early
onset of severe periodontitis and are forced to undergo tooth extraction. Here, we report a case of a patient with CyN who
showed different periodicity and oscillations of neutrophil count compared with her mother, despite sharing the same novel genetic
mutation.
Patient concerns: A 17-year-old Japanese girl who had been diagnosed with CyN shortly after birth presented to our hospital
with a complaint of mobility of her teeth and gingivitis. Upon presentation, an intraoral examination was performed and revealed
redness and swelling of the marginal and attached gingiva. Radiographs revealed extreme resorption of the alveolar bone and apical
lesions in her mandibular lateral incisors. The patient’s hematologic data demonstrated a lack of blood neutrophils (0/mL). The patient
had no history of dental extraction, and her mother also had a history of CyN.
Diagnoses: The patient was diagnosed with severe periodontitis that was associated with CyN. Gene testing showed a novel
heterozygous mutation in exon 4 of the ELANE gene (c.538delC, p.Leu180Ser fsX11).
Interventions: Based on the clinical findings, we planned to extract the patient’s mandibular lateral incisors. Although the tooth
extraction was scheduled considering the cyclic variation in neutrophil count, the patient’s neutrophil count was 0/mL on the day
before the planned extraction. Therefore, granulocyte-colony stimulating factor (G-CSF) was administered to increase the patient’s
neutrophil count. On the day of the patient’s admission for the tooth extraction, she presented with fever (body temperature, 38.5°C),
tonsillitis, and stomatitis. The extraction was subsequently delayed, and the patient was administered antibiotics and G-CSF for
4 days. At this time, the neutrophil count increased to 750/mL, and the tooth extraction was carried out safely.
Outcomes: The postoperative course was uneventful, and the healing process at the extraction site was excellent.
Conclusion: There is a possibility that the periodicity and oscillations of neutrophil count may change with growth in patients with
CyN. Therefore, it is important to frequently examine and treat patients with fluctuating neutrophil levels for the management of
invasive dental treatment in patients with CyN.
Abbreviations: AML = acute myeloid leukemia, ANC = absolute neutrophil count, CyN = cyclic neutropenia, ELANE = neutrophil
elastase, G-CSF = granulocyte-colony stimulating factor, SCN = severe congenial neutropenia, SSI = surgical site infection.
Keywords: cyclic neutropenia, ELANE gene, G-CSF, periodontitis, tooth extraction
1. Introduction
Cyclic neutropenia (CyN) is a rare hematological disease
characterized by periodic neutropenia, with an average 21-day
turnover frequency.[1] Neutropenia is defined as the absolute
neutrophil count (ANC) and is categorized as mild (ANC: 1000–
1500/mL), moderate (ANC: 500–1000/mL), or severe (ANC:
<500/mL).[2] Common causes of neutropenia include cancer
chemotherapy, autoimmune diseases, drug reaction, and heredi-
tary disorders. The 2 primary genetic forms of neutropenia are
CyN and severe congenital neutropenia (SCN).[3] CyN and SCN
are usually caused by heterozygous mutations in the gene that
encodes neutrophil elastase, ELANE.[4–6] CyN is characterized
by severe neutropenia (ANC: <0.2109/L) and frequent
opportunistic infections, including fever, mouth ulcers, gingivitis,
lymphadenopathy, pharyngitis/tonsillitis, and bacterial infec-
tions, during the recurrent neutropenic periods.[7,8] In contrast,
patients with SCN usually have an ANC <0.5109/L,[9] more
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serious infections, and may develop acute myeloid leukemia
(AML).[10,11]
The clinical presentation of CyN was first described in 1910
based on the recurrence of neutropenia, fever, and mouth ulcers
in a 19-month-old boy.[12] Although the pathogenesis of the
disease has not been completely elucidated, the locus for
autosomal dominant cyclic neutropenia is mapped to chromo-
some 19p13.3, and this disease is attributable to heterozygous
mutations of ELANE.[5,6] Heterozygous mutations in the
ELANE gene have been reported in a high frequency of single
base pair/amino acid mutations[13] and identified in 80% to
100% of patients with CyN.[3–6] Most laboratory investigations
have indicated that mutations in the ELANE gene initiate the
unfolded protein response, accelerate apoptosis if developing
myeloid cells, and result in ineffective myelopoiesis.[14–17]
Patients with CyN exhibit oral manifestations, including
aphthous ulcers (on fixed or removable mucosa), gingivitis, and
periodontitis with alveolar bone loss. These symptoms usually
occur around early childhood.[4] Systemic symptoms, such as
fever, generally diminish after adolescence, but adults with CyN
continue to experience oral ulcers, gingivitis, and periodonti-
tis.[4,18] Thus, oral hygiene management in CyN patients is very
important, and infection control should be considered before any
invasive dental treatment is performed. Here, we describe the case
of a 17-year-old Japanese girl with CyN fromwhomwewere able
to successfully extract the mandibular lateral incisors following
the administration of recombinant granulocyte-colony stimulat-
ing factor (G-CSF) and antibiotics for several days before the
extraction. In addition, this patient exhibited a novel heterozy-
gous mutation exon 4 of the ELANE gene. Our results
demonstrate the importance of managing invasive dental
treatment for patients with CyN.
2. Case presentation
2.1. Presenting concerns
A 17-year-old Japanese girl who had been diagnosed with CyN
presented to our hospital with a complaint of mobility of her teeth
and gingivitis.
The patient exhibited sepsis at 3 months of age. At 1.5 years of
age, bone marrow aspirate showed “maturation arrest” at the
promyelocyte or myelocyte stage of neutrophil formation, and
she was diagnosed with CyN. From this point forward, the
patient had continuously experienced recurrent fevers due to
tonsillitis, stomatitis, herpetic stomatitis, and perianal abscesses
once a month. Therefore, she had to be hospitalized once or twice
per year until she was 15 years of age. Although the recurrence of
fever gradually ceased, stomatitis and gingivitis continued to
occur, and she developed mobility of the mandibular anterior
teeth at 16 years of age.
The patient underwent oral hygiene preventive therapy from
early childhood, which was managed by her general dentist.
Severe stomatitis frequently interfered with the patient’s ability to
brush her teeth after meals. At 16 years of age, her general dentist
made a fixed bridge on her mandibular anterior teeth due to the
congenital deficiency of her mandibular central incisors, and the
patient underwent pulpectomy of her mandibular lateral incisors
at this time. At 17 years of age, the patient presented to the
Department of Periodontology and Endodontology at Tokush-
ima University Hospital because the mobility of her mandibular
lateral incisors became severe. The patient’s mother also had a
history of CyN; however, her father and 2 older brothers were
healthy.
2.2. Clinical findings
An intraoral examination revealed redness and swelling of the
marginal and attached gingiva (Fig. 1), a panoramic radiograph
showed extreme resorption of the alveolar bone (Fig. 2A), and
dental radiographs indicated apical lesions in the mandibular
lateral incisors (Fig. 2B). The fixed bridge on the mandibular
lateral incisors was attached due to the congenital deficiency of
her mandibular central incisors. During the clinical examination,
the patient exhibited bleeding on probing (BOP, %) that
exceeded 25% and alveolar bone loss that was greater than a
three-walled periodontal bone defect and periodontal pockets
that exceeded 4mm around the same teeth; these symptoms were
indicative of gingivitis and periodontitis, respectively. Therefore,
the patient was diagnosed with CyN-associated gingivitis and
periodontitis. We also measured the serum levels of periodontally
associated microorganisms. Our patient exhibited significantly
higher levels of Prevotella intermedia, Porphyromonas gingivalis,
Campylobacter rectus, Treponema denticola, and Tannerella
forsythia than control subjects of the same generation. The
patient’s periodontal care was initiated by a periodontist, and her
mandibular lateral incisors were deemed nonrestorable by the
periodontist; therefore, the mandibular lateral incisors needed to
be extracted.
2.3. Diagnostic assessment
The hematologic data on the day of the patient’s first visit to our
hospital are shown in Table 1. A lack of blood neutrophils (0/mL)
and an increased monocyte count (1681/mL) were observed.
Total white blood cell (WBC) or leukocyte counts (4100/mL),
including lymphocytes (2009/mL), monocytes (1681/mL), eosin-
ophils (307.5/mL), and basophils (102.5/mL), were within normal
limits (Table 1). Before tooth extraction, an investigation of the
patient’s neutropenic cycle, blood testing was conducted over a
period of 3 months. As shown in Figure 3A, her neutrophil count
was cycled from 0/mL and 1400/mL, whereas themonocyte cycled
from 1680/mL to 610/mL (Fig. 3A). In contrast, neutrophil counts
Figure 1. Intraoral view showing redness and swelling of the marginal and
attached gingiva.
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of the patient’s 46-year-old mother did not appear to oscillate;
neutrophils ranged between 60 and 120/mL (Fig. 3B).
2.4. Therapeutic intervention
Based on the patient’s blood test results, we planned to extract her
mandibular lateral incisors in the hospital during her spring
vacation when her neutrophil count was high. The patient was
hospitalized 84 days following her initial visit to our department.
However, one day before her admission, the patient’s body
temperature was 37.4°C and she exhibited erythematous
vesicular-bullous lesions (from the second to the third thoracic
nerve segments) on the right side of her body. One of our
hospital’s dermatologists performed a biopsy and detected herpes
zoster virus giant cells. The patient was subsequently diagnosed
with a herpes zoster infection and treated with an internal
medication of amenamevir (Amenalief, Maruho Co., Ltd., Japan)
(400mg/d) for 7 days. On the day of the biopsy, blood tests
Figure 2. (A) Panoramic radiograph showing extreme resorption of alveolar bone. (B) Dental radiograph demonstrating apical lesions in teeth #32 and #42 (yellow
arrows).
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Table 1
Laboratory data on the day of the patient’s first visit.
Hematology Normal range Biochemistry Normal range
WBC 4100/mL 3300–8600/mL TP 7.7 g/dL 6.6–8.1 g/dL
Neutro 0/mL (0.0%) 40%–70% ALB 3.7 g/dL 4.1–5.1 g/dL
Lymph 2009/mL (49.0%) 20%–50% T-BIL 0.7 mg/dL 0.4–1.5 mg/dL
Mono 1681/mL (41.0%) 0%–10% AST 14 U/L 13–30 U/L
Eosino 307.5/mL (7.5%) 1%–5% ALT 8 U/L 7–23 U/L
Baso 102.5/mL (2.5%) 0%–1% BUN 8 mg/dL 8–20 mg/dL
RBC 3.81106/mL 3.80–5.00106/mL Cre 0.34 mg/dL 0.46–0.79 mg/dL
Hb 11.4 g/dL 11.5–15.0 g/dL Na 138 mEq/L 138–145 mEq/L
Ht 34.7% 35%–45% K 3.8 mEq/L 3.6–4.8 mEq/L
PLT 40.7104/mL 15–35104/mL Cl 102 mEq/L 101–108 mEq/L
Blood coagulation test Normal range CRP 1.61 mg/dL 0.00–0.14 mg/dL
PT 12.9 s 10.5–13.4 s
APTT 31.1 s 24.3–35.0 s
ALB= albumin, ALT= alanine aminotransferase, APTT= activated partial thromboplastin time, AST= aspartate aminotransferase, Baso=basophil, BUN=blood urea nitrogen, Cl= chlorine, Cre= creatinine,
CRP=C-reactive protein, Eosino= eosinophil, Hb=hemoglobin, Ht=hematocrit, K=potassium, Lymph= lymphocyte, Mono=monocyte, Na= sodium, Neutro=neutrophil, PLT=platelet, PT=prothrombin





























































Figure 3. Changes in the WBC, neutrophils, lymphocytes, and monocytes over the course of 3 months. (A) The 17-year-old patient’s neutrophil counts appeared
to cycle between the range of 0 and 1400/mL, and the monocyte counts show an inverse cycle when compared to the neutrophil counts. (B) The neutrophil counts
of the patient’s 46-year-old mother did not appear to oscillate, and they ranged between 60 and 120/mL. Lymph= lymphocyte, Mono=monocyte, Neutro=
neutrophil, WBC=white blood cell.
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revealed a WBC count of 3500/mL, neutrophil count of 0/mL
(0%), monocyte count of 2030/mL (58.0%), and C-reactive
protein (CRP) level of 7.81mg/dL. Granulocyte-colony stimulat-
ing factor (G-CSF) (Lenograstim, Neutrojin, Chugai Pharmaceu-
tical Co., Ltd., Japan) (2mg/kg) was subcutaneously administered
to prevent bacterial infection.
On the day of the patient’s admission for tooth extraction, she
developed a fever (body temperature, 38.5°C), which was
accompanied by tonsillitis and stomatitis (Fig. 4). The tooth
extraction was canceled, and meropenem hydrate (Meropen,
Sumitomo Dainippon Pharma Co., Ltd., Japan) (1.5g/d) was
intravenously administered. Because her neutrophil count was
still low (50/mL [1%]), a second dose of G-CSF (2mg/kg) was
administered subcutaneously. The following day, the patient’s
body temperature increased to 39.9°C, and blood tests revealed a
WBC count of 4800/mL, neutrophil count of 0/mL (0%),
monocyte count of 2890/mL (60%), and CRP level of 12.24
mg/dL. G-CSF treatment was continued daily for 4 days, and
therapy with antibiotics was continued daily for 5 days until the
tooth extraction was completed. Three days after the patient’s
admission, her clinical symptoms improved. Her body tempera-
ture dropped to 37.0°C, and her neutrophil count increased to
750/mL (13%) (Fig. 5). Based on the patient’s improved clinical
condition, we decided to perform the tooth extraction.
Local anesthesia was administered into the gingiva around the
mandibular lateral incisors using 1.8mL of 2% lidocaine with
1:80,000 epinephrine. The mandibular lateral incisors were
extracted without damaging the gingival soft tissue. The
extraction sockets were sutured with 4-0 silk suture. No
significant bleeding was observed during or after the procedure.
The patient was discharged the next day without fever.
Meropenem hydrate (Meropen) (1.5g/d) was used as an
antibiotic for 4 days before the procedure and one day after the
Figure 4. Oral manifestations on admission. A photo of the patient’s oral cavity
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Figure 5. The clinical course after admission. The patient presented with severe neutropenia and an infection with herpes zoster one day before her admission. On
the day of admission, she developed a fever that was accompanied by tonsillitis and stomatitis. The clinical symptoms improved after antibiotic and antiviral therapy.
The neutrophil count increased to 750/mL after the administration of G-CSF for 4 days. On the fourth day of admission, the extraction of two teeth was carried out
safely. BT=body temperature, CRP=C-reactive protein, G-CSF=granulocyte-colony stimulating factor, Lymph= lymphocyte, MEPM=meropenem hydrate,
Mono=monocyte, Neutro=neutrophil, WBC=white blood cell.
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procedure. Cefditoren pivoxil (Meiact MS, Meiji Seika Pharma
Co., Ltd., Japan) (300mg/d) was used for 3 days from the second
day after the procedure. In brief, antibiotic was administered for
4 days preoperatively and 4 days postoperatively. The patient did
not exhibit postoperative infection, postoperative pain, or
delayed healing.
2.5. Follow-up and outcomes
A follow-up examination 1 week later revealed excellent healing
at the extraction site. The herpes zoster infection had resolved,
and no other infections were observed. Temporary teeth were
provided and treatment for periodontal disease was continued by
her periodontist.
Despite our patient’s diagnosis of CyN, based on the clinical
course and results of a bone marrow examination, her cycle of
neutropenia was not typical and differed from our prediction.
The patient and her mother therefore underwent testing for CyN-
related genes such as ELANE using a polymerase chain reaction
analysis and direct sequencing (Hiroshima University). A novel
heterozygous sequence variation was noted in exon 4 of the
ELANE gene (c.538delC, p.Leu180Ser fsX11) (Fig. 6A). The
same mutation was detected in the patient’s mother (Fig. 6B).
This variation was not found in the Human Gene Mutation
Database.
3. Discussion
Here, we reported the identification of a familial case of CyN
resulting from a novel heterozygous mutation in the ELANE
gene, which encodes neutrophil elastase. This protease is
synthesized and packaged in promyelocytes at an early stage
in neutrophil development. The etiology of ELANE-related
neutropenia is attributed tomutations in theELANE gene, which
induce unfolded protein response-associated apoptosis at the
promyelocyte stage and result in ineffective myelopoiesis.[14–17]
Heterozygous mutations in the ELANE gene are reported to be
found in 80% to 100% of patients with CyN.[3–6]ELANE
heterozygosity has also been identified in 35% to 69%of patients
with SCN.[9,19–23] A previous study reported that 187 SCN
patients and 120 CyN patients had 94 and 22 mutations in the
ELANE gene, respectively. In addition, patients with CyN and
SCN had 104 distinct ELANE mutations.[13] The 104 different
ELANE mutations comprised 65 missense, 15 frameshift, 8
termination, 8 intronic, 7 in-frame deletions or insertions, and 1
unknown.[13] Most mutations in cases of CyN are observed in
exons 4 and 5.[13] Interestingly, the heterozygous variation (p.
Leu180Ser missense variant of ELANE gene) observed in our
patient has not been previously reported in the literature.
Therefore, the p.Leu180Ser missense variant of the ELANE gene
may negatively affect neutrophil elastase function, which plays a
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Figure 6. DNA sequence analysis of the ELANE gene. Note that both the patient (A) and her mother (B) carry the same mutation (c.538delC, p.Leu180Ser fsX11).
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Neutrophils are key immune cells for oral health, and
neutrophil deficiency or dysfunction often result in periodontal
disease.[24] It has been recognized that patients with CyN often
exhibit an early onset of severe periodontitis.[25–27] Conversely,
patients with SCN that harbor mutations in the ELANE gene
present with more severe periodontal diseases as compared with
patients with HAX1 mutations or other unknown mutations.[18]
Our patient also presented with severe periodontitis. We
measured serum levels of periodontally associated microorgan-
isms and found that the levels of periodontal microorganisms
were significantly higher in our patient than control subjects of
the same generation. Thus, deficiency in periodontal neutrophils
associated with ELANE gene mutations may influence the
subgingival microbiota composition in the periodontal pocket,
leading to the pathogenesis of periodontal breakdown. In
addition, the patient could not brush her teeth due to pain
during episodes of recurrent stomatitis. Thus, poor oral hygiene
may have influenced the development of periodontal disease.
Variations of CyN include fluctuations in neutrophils that can
last as long as 3 weeks (probably <5% of individuals) and a
reduced amplitude of oscillations.[4] Neutrophil counts in
children tend to oscillate more obviously than in adults.[4] The
17-year-old patient’s neutrophil cycle appeared to oscillate
markedly (range: 0–1400/mL), whereas her 46-year-old mother’s
cycle showed little oscillation (range: 60–120/mL) despite the
same ELANE gene mutation. The precise mechanism of
oscillations in CyN is not understood, but mutations in the
ELANE gene are capable of causing the mislocalization of
neutrophil elastase and may also induce the unfolded protein
response.[3] Neutrophil elastase is produced by the terminally
differentiating cohort of neutrophils and ultimately feeds back to
inhibit further production of neutrophils, which results in brief
interruption of the inhibitory cycle until production of
neutrophils resumes, followed again by the inhibitory action of
neutrophil elastase in a cyclic manner.[3] Although oscillations in
CyN were previously thought to be caused by mutations in the
ELANE gene, cyclic variations in the neutrophil counts of our
patient and her mother were markedly different, although they
shared the same ELANE mutation. Therefore, the periodicity
and oscillations of neutrophil count may involve other factors,
such as hormones, in addition to gene mutations.
The perioperative management of patients with CyN requires
the prevention and control of infection. Neutropenia is the major
cause of surgical site infection (SSI), fever, and sepsis. We
discovered only 2 articles with the key words “CyN” and “tooth
extraction” that described the cases of a 14-year-old boy and a
15-year-old girl who had been diagnosed with CyN, had
periodontal disease, and needed to have their teeth
extracted.[26,28] Their invasive dental treatment was performed
safely by avoiding the neutropenic cycle and administering
antibiotics.
There have been several reports of the perioperative manage-
ment of invasive dental procedures for patients with neutropenia.
Fillmore et al[29] investigated the complications of dental
extractions in 116 neutropenic patients. Forty-two percent of
the patients showed severe neutropenia (0–499/mL). The main
diagnoses associated with neutropenia were myeloid leukemia,
lymphoma, lymphoid leukemia, multiple myeloma, pancytope-
nia or aplastic anemia, myelodysplastic syndrome, and amyloid-
osis. Most of the patients received preoperative antibiotic
coverage; the mean duration of preoperative antibiotic treatment
was 2.6±4.85 days (range, 0–30 days), whereas the mean
duration of postoperative antibiotic treatment was 4.6±8.78
days (range, 0–60 days). The most commonly used antibiotics
were meropenem, cefazolin, clindamycin, cefepime, ampicillin,
sulbactam, and vancomycin. Twenty-one patients showed a
mean ANC of 691/mL; these patients were administered G-CSF.
The overall rate of complications was 8.6% (n=10), including
delayed healing, SSI, and prolonged postoperative pain.
Overholser et al[30] studied dental extractions in 28 patients
with acute nonlymphocytic leukemia. Their protocol involved no
extraction in patients with severe neutropenia (<500/mL),
antibiotic coverage for patients with granulocyte counts
<2000/mL, and primary closure of the extraction site. They
found no major postoperative complications and 1 patient with
SSI.
In the present case, the patient’s surgical procedure was
scheduled based on a prediction of increased levels of neutrophils.
However, contrary to our prediction, the number of neutrophils
on the day before her surgery was 0/mL (0%). She additionally
developed herpes zoster, tonsillitis, and a fever. The tooth
extraction was canceled, and the administration of G-CSF,
antibiotics, and antiviral drugs supported the recovery of her
general condition. The administration of G-CSF (2mg/kg) for 4
days was effective in increasing her neutrophil count. The
extraction of her teeth and the healing process were successful,
and there was no evidence of SSI or fever.
As in this case, the periodicity and oscillations of neutrophil
count may change during the course of growth. To avoid
complications, it is important to manage invasive dental
treatment in patients with CyN by frequently examining
neutrophil counts and appropriately treating patients with G-
CSF and antibiotics. There are some limitations of the case report
or its management.
3.1. Patient perspective
Patient Consent Statement: The patient and her mother provided
informed consent for publication of the case.
3.2. Ethical review and informed consent
This case report was approved by the Ethics Committee of
Tokushima University (authorization no. 3236) and the Human
Genome/Gene Analysis Research Committee of Tokushima
University (authorization no. H30-13). The patient and her
mother provided written informed consent.
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